Celiac & Gluten Genetic Screening — Can Your DNA Rule Out Celiac Disease?
HLA-DQ2 and HLA-DQ8 screening from your existing 23andMe or AncestryDNA data — $19, results in minutes.
Do you actually need to avoid gluten?
If you lack the HLA-DQ2 and HLA-DQ8 genes, celiac disease is essentially ruled out — with greater than 99% confidence. About 60% of the population gets this answer. For $19 and your existing DNA data, you can find out in minutes whether a gluten-free diet is genetically warranted or unnecessary.
What This Screening Does
This screening checks whether you carry the HLA-DQ2 or HLA-DQ8 genes required for celiac disease. Its primary value is ruling OUT celiac disease: if you lack both genes, celiac is essentially excluded with over 99% negative predictive value.
A positive result (carrier detected) does NOT mean you have celiac. It means celiac cannot be genetically excluded and further evaluation may be appropriate if you have symptoms.
Who Should Consider This
- GI symptoms without a diagnosis — chronic bloating, diarrhea, abdominal pain, or unexplained weight loss that could be celiac-related.
- Family history of celiac disease — first-degree relatives of celiac patients have a 10-15% lifetime risk.
- Considering a gluten-free diet — genetic screening can determine whether celiac is even possible before making dietary changes.
- Already on a gluten-free diet — HLA-DQ screening works regardless of diet, unlike blood tests which require active gluten consumption.
How It Works
- Upload your DNA data from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA (or use data you've already uploaded).
- HLA-DQ2 and HLA-DQ8 variants in your raw data are analyzed for celiac susceptibility haplotypes.
- Receive your screening result with carrier status, interpretation, and personalized next steps.
Key Clinical Evidence
- Negative predictive value >99%: Absence of both HLA-DQ2 and HLA-DQ8 essentially excludes celiac disease. This is one of the strongest genetic exclusion tests in clinical medicine.
- HLA-DQ2.5 prevalence: Found in 90-95% of celiac patients and 20-30% of the general population. Necessary but not sufficient for disease.
- Carrier vs. disease rate: 25-40% of the population carries DQ2 or DQ8, but only about 3% of carriers develop celiac disease.
- Diet-independent: Unlike TTG-IgA blood tests, HLA-DQ screening is unaffected by gluten intake, making it useful for patients already on a gluten-free diet.
Screen Your Celiac Risk — $19
Upload your 23andMe or AncestryDNA data (or use an existing upload) to receive your personalized Celiac & Gluten Screening.
Upload DNA & Get Screening — $19One-time purchase · Results in minutes · No lab visit needed
Celiac vs. Gluten Sensitivity vs. Wheat Allergy
These three conditions are often confused but have different mechanisms, testing, and clinical significance:
| Celiac Disease | Gluten Sensitivity | Wheat Allergy | |
|---|---|---|---|
| Mechanism | Autoimmune | Unknown (non-autoimmune) | IgE-mediated allergy |
| HLA-DQ required | Yes (DQ2 or DQ8) | No | No |
| Intestinal damage | Yes (villous atrophy) | No | No |
| Diagnostic test | TTG-IgA + biopsy | Exclusion diagnosis | Skin prick / IgE blood test |
| Genetic screening | Can rule out (>99% NPV) | Not applicable | Not applicable |
This screening specifically addresses celiac disease. If your result is negative (no DQ2 or DQ8), celiac is excluded — but gluten sensitivity and wheat allergy remain possible and require different evaluation.
Limitations
- This screening can rule out celiac disease but cannot diagnose it. A positive HLA-DQ result indicates susceptibility, not active disease.
- Consumer genotyping chips use tag SNPs for HLA-DQ haplotypes rather than full HLA sequencing. Rare haplotype combinations may not be captured.
- Non-celiac gluten sensitivity and wheat allergy are not detectable through HLA-DQ screening.
- This screening does not replace clinical evaluation, TTG-IgA blood testing, or intestinal biopsy.
Disclaimer
This screening is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. A positive result does not mean you have celiac disease, and a negative result does not guarantee you are free of all gluten-related conditions. Consult a gastroenterologist or healthcare provider for clinical evaluation and diagnosis. Do not start or stop a gluten-free diet based solely on this screening result.
Learn More
- Sample Celiac Screening Report — preview the report format before purchasing
- Can you test for celiac from 23andMe raw data? — detailed guide to HLA-DQ screening from consumer DNA
- Should I go gluten-free? — what your DNA can tell you before changing your diet
Explore More from Your DNA
Your uploaded DNA data can also reveal how your body processes medications, nutrients, and more:
- Nutrition & Methylation Report — How your DNA affects folate, B12, vitamin D, and other nutrient metabolism — $39.
- Pain & Anesthesia Report — Find out if codeine works for you and how your genetics affect pain sensitivity — $39.
- Cannabis & CBD Report — How your CYP enzymes affect THC and CBD metabolism — $29.
References
- Karell K et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer. Hum Immunol. 2003;64(4):469-77. PMID: 12651074.
- Sollid LM, Lie BA. Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol. 2005;3(9):843-51. PMID: 16234020.
- Husby S et al. European Society Paediatric Gastroenterology, Hepatology and Nutrition guidelines for diagnosing coeliac disease 2020. J Pediatr Gastroenterol Nutr. 2020;70(1):141-56. PMID: 31568151.
- Rubio-Tapia A et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108(5):656-76. PMID: 23609613.
- Megiorni F, Pizzuti A. HLA-DQA1 and HLA-DQB1 in celiac disease predisposition. World J Gastroenterol. 2012;18(33):4523-31. PMID: 22969222.